Public Health

All posts tagged Public Health

WorldLeish.jpg

WorldLeish 2017 Conference

WorldLeish | 16 – 20 May 2017 | Toledo, Spain | 1500 participants |  6th World Congress on Leishmaniasis, organized once every 4 years

Erasmus MC was represented by Epke Le Rutte and Sake de Vlas from the Department of Public Health, who were invited speaker and co-chair respectively of the session “quantitative studies of leishmaniasis transmission and control” in which they highlighted the key policy relevant outcomes of their most recent modeling work on visceral leishmaniasis. In a different session, Epke also presented the work performed at the Department of Public Health at Erasmus MC in collaboration with the faculty of Veterinary Medicine at Utrecht University on the awareness and implementation of control measures by veterinarians against the spread of zoonotic visceral leishmaniasis in Spain and France.

read more
RGHI CommunicationsWorldLeish 2017 Conference

Imperial College research seminar | 22 May 2017 | London, UK

Natalie Vinkeles Melchers (Erasmus MC, Department of Public Health) was invited as a guest speaker to a research seminar at the Imperial Collage in London (UK). Natalie presented her work on the projected number of people with onchocerciasis-loiasis co-infection in Africa, from 1995 to 2025. Onchocerciasis, also known as river blindness, is a disease caused by infection with the nematode worm Onchocerca volvulus. Long-term infection may ultimately lead to blindness. Ivermectin is the drug used at a large-scale in onchocerciasis elimination programmes. However, for individuals that are co-infected with Loa loa, the African eye worm, ivermectin may cause severe adverse events (SAEs), potentially even death. The seminar presented estimations on how many people would be at risk of SAEs and how many people would thus benefit from alternative treatment strategies and drugs for onchocerciasis in L. loa endemic areas.

read more
RGHI CommunicationsImperial College research seminar | 22 May 2017 | London, UK

World Health Organization | 23 March 2017 | Geneva, Switzerland

Natalie Vinkeles Melchers, Wilma Stolk and Luc Coffeng from the Erasmus MC (Department of Public Health) were invited to the World Health Organization (WHO), Department of Neglected Tropical Diseases, to discuss their work on a modeling study on the impact of ivermectin on skin and eye disease due to onchocerciasis with projections up to 2025. Drs. Vinkeles Melchers presented her recent work, and showed an expanded disease framework within the individual-based mathematical ONCHOSIM model. She used the disease module to predict trends in the prevalence of onchocercal eye and skin disease during a 25-year time frame since start of MDA. Predicted prevalence was projected for various clinical manifestations due to onchocerciasis; reversible conditions (itch and reactive skin disease) and irreversible manifestations (skin atrophy, depigmentation, hanging groin, vision loss). The meeting was attended by WHO experts in the field of, among others,  onchocerciasis, lymphatic filariasis, Chagas, and was deemed very successful.

 

read more
RGHI CommunicationsWorld Health Organization | 23 March 2017 | Geneva, Switzerland
viruskenner.png

Erasmus MC ‘Viruskenner’ Interesting Aid in Prevention and Spread of Viral Diseases

The Zika outbreak and its consequences show how important public information is in prevention and control of infectious diseases.
The WHO declared a global health emergency for Zika in February and announced last week that there is strong scientific consensus that Zika virus can cause GBS, microcephaly and other neurological disorders.

read more
RGHI AdministratorErasmus MC ‘Viruskenner’ Interesting Aid in Prevention and Spread of Viral Diseases
pariscop21.jpg

Paris COP21 – Climate Change and Health

This week, in Paris the international climate conference COP21 takes place. In June, the Lancet Commission on Health and Climate Change launched a seminal research report, which underscores that “responding to climate change could be the biggest global health opportunity of the 21st century.” The report provides key policy recommendations for governments to take action in the next five years.

read more
RGHI AdministratorParis COP21 – Climate Change and Health

Terug naar de voorhoede van gezondheidsinnovatie. Kies voor een Global Health orientatie op gezondheid

Een echte innovatie agenda begint ermee de debatten rond een aantal grote thema’s zoals gezondheidszorg echt anders in te richten. Hiertoe doet een grote coalitie van gezondheidszorginstellingen en kenniscentra een oproep aan de informateurs. De coalitie pleit voor een omslag van gezondheidskosten naar een batenagenda en een nieuwe global health oriëntatie op gezondheid en zorg. Nederland moet uit de schulp als het gaat om inzet van onze kennis op de grote gezondheidsthema’s. De coalitie pleit voor een NL regering die daar rugdekking aan geeft en hierdoor ook veel meer kansen biedt voor de vele kleine vernieuwende bedrijven die Nederland op het terrein van gezondheid rijk is. Een gerichte global health oriëntatie kan voeding geven aan een topsectoren-plus beleid dat kennisvernieuwing, research en innovatieve kleinere gezondheidsbedrijven ruimte biedt om oplossingen voor de grote gezondheidsuitdagingen te ontwikkelen.

read more

RGHI AdministratorTerug naar de voorhoede van gezondheidsinnovatie. Kies voor een Global Health orientatie op gezondheid